BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 30076742)

  • 1. Iron metabolism gene expression and prognostic features of hepatocellular carcinoma.
    Shen Y; Li X; Zhao B; Xue Y; Wang S; Chen X; Yang J; Lv H; Shang P
    J Cell Biochem; 2018 Nov; 119(11):9178-9204. PubMed ID: 30076742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene signatures and prognostic values of m1A-related regulatory genes in hepatocellular carcinoma.
    Shi Q; Xue C; Yuan X; He Y; Yu Z
    Sci Rep; 2020 Sep; 10(1):15083. PubMed ID: 32934298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five Core Genes Related to the Progression and Prognosis of Hepatocellular Carcinoma Identified by Analysis of a Coexpression Network.
    Kong J; Wang T; Zhang Z; Yang X; Shen S; Wang W
    DNA Cell Biol; 2019 Dec; 38(12):1564-1576. PubMed ID: 31633379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-Testis Gene Expression in Hepatocellular Carcinoma: Identification of Prognostic Markers and Potential Targets for Immunotherapy.
    Zhang YP; Bao ZW; Wu JB; Chen YH; Chen JR; Xie HY; Zhou L; Wu J; Zheng SS
    Technol Cancer Res Treat; 2020; 19():1533033820944274. PubMed ID: 32715976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
    Lu M; Kong X; Wang H; Huang G; Ye C; He Z
    Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of cancer stem cell characteristics in liver hepatocellular carcinoma by WGCNA analysis of transcriptome stemness index.
    Bai KH; He SY; Shu LL; Wang WD; Lin SY; Zhang QY; Li L; Cheng L; Dai YJ
    Cancer Med; 2020 Jun; 9(12):4290-4298. PubMed ID: 32311840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Cancer Genome Atlas (TCGA) based m
    Liu J; Sun G; Pan S; Qin M; Ouyang R; Li Z; Huang J
    Bioengineered; 2020 Dec; 11(1):759-768. PubMed ID: 32631107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel four-gene of iron metabolism-related and methylated for prognosis prediction of hepatocellular carcinoma.
    Shen H; Wu H; Sun F; Qi J; Zhu Q
    Bioengineered; 2021 Dec; 12(1):240-251. PubMed ID: 33380233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma.
    Ren FH; Yang H; He RQ; Lu JN; Lin XG; Liang HW; Dang YW; Feng ZB; Chen G; Luo DZ
    BMC Cancer; 2018 Jan; 18(1):12. PubMed ID: 29298665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of potential key genes in very early hepatocellular carcinoma.
    Wu M; Liu Z; Li X; Zhang A; Lin D; Li N
    World J Surg Oncol; 2019 May; 17(1):77. PubMed ID: 31043166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value and underlying mechanism of KIAA0101 in hepatocellular carcinoma: database mining and co-expression analysis.
    Xu W; Wang X; Wu X; Yu S; Xiong J; Sang X; Zheng Y; Zhang Z
    Aging (Albany NY); 2020 Aug; 12(16):16420-16436. PubMed ID: 32855364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic roles of metabolic reprogramming-associated genes in patients with hepatocellular carcinoma.
    Cui L; Xue H; Wen Z; Lu Z; Liu Y; Zhang Y
    Aging (Albany NY); 2020 Nov; 12(21):22199-22219. PubMed ID: 33188160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low DMT1 Expression Associates With Increased Oxidative Phosphorylation and Early Recurrence in Hepatocellular Carcinoma.
    Hoki T; Katsuta E; Yan L; Takabe K; Ito F
    J Surg Res; 2019 Feb; 234():343-352. PubMed ID: 30527495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of heterogeneous redox responses in hepatocellular carcinoma patients using network analysis.
    Benfeitas R; Bidkhori G; Mukhopadhyay B; Klevstig M; Arif M; Zhang C; Lee S; Cinar R; Nielsen J; Uhlen M; Boren J; Kunos G; Mardinoglu A
    EBioMedicine; 2019 Feb; 40():471-487. PubMed ID: 30606699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatics identification of crucial genes and pathways associated with hepatocellular carcinoma.
    Gao X; Wang X; Zhang S
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30341252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mining TCGA Database for Tumor Microenvironment-Related Genes of Prognostic Value in Hepatocellular Carcinoma.
    Deng Z; Wang J; Xu B; Jin Z; Wu G; Zeng J; Peng M; Guo Y; Wen Z
    Biomed Res Int; 2019; 2019():2408348. PubMed ID: 31828095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene network analysis reveals a novel 22-gene signature of carbon metabolism in hepatocellular carcinoma.
    Zhang J; Baddoo M; Han C; Strong MJ; Cvitanovic J; Moroz K; Dash S; Flemington EK; Wu T
    Oncotarget; 2016 Aug; 7(31):49232-49245. PubMed ID: 27363021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SEMA3F Promotes Liver Hepatocellular Carcinoma Metastasis by Activating Focal Adhesion Pathway.
    Ye K; Ouyang X; Wang Z; Yao L; Zhang G
    DNA Cell Biol; 2020 Mar; 39(3):474-483. PubMed ID: 31968181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.